Hexan-3-Ol

Hexan-3-Ol

SCHEMBL464395

CCC[C@H](O)CC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexan-3-Ol SCHEMBL15033 1.00
Hexan-3-Ol SCHEMBL11796163 1.00 LMNA (0.43)
Hexan-3-Ol SCHEMBL1462441 1.00
Hexan-3-Ol SCHEMBL27558536 0.97
Hexan-3-Ol SCHEMBL28179662 0.97
Hexan-3-Ol SCHEMBL20916928 0.97
Hexan-3-Ol SCHEMBL6014577 0.97
Hexan-3-Ol SCHEMBL27896438 0.97
SCHEMBL412444 0.94 LMNA (0.40)
Hexan-3-Ol SCHEMBL27323948 0.94 TSHR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282736-A1 SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR ST JUDE CHILDRENS RES HOSPITAL (US) 2025-09-11 US disclosed
WO-2025096734-A1 MICROCAPSULES FMC CORPORATION (US) 2025-05-08 WO disclosed
WO-2023205344-A1 SMALL MOLECULE MODULATORS OF HUMAN PREGNANE X RECEPTOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2023-10-26 WO disclosed
US-20170283424-A1 PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS GENENTECH, INC. (US) 2017-10-05 US disclosed
US-20150152117-A1 PYRAZOLOPYRIMIDINE JAK INHIBITOR COMPOUNDS AND METHODS GENENTECH, INC. (US) 2015-06-04 US disclosed
US-8999998-B2 Pyrazolopyrimidine JAK inhibitor compounds and methods GENENTECH, INC. (US) 2015-04-07 US disclosed
EP-2070507-B1 Hardening composition DENTSPLY DETREY GMBH (DE) 2013-09-04 EP disclosed
EP-2361244-B1 A PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE N-BENZYL-3 HYDROXYPYRROLIDINES COUNCIL SCIENT IND RES (IN) 2013-07-10 EP disclosed
US-8440740-B2 Dental glass compositions utilizing a glass ionomer and an acidic copolymer DENTSPLY INTERNATIONAL INC. (US) 2013-05-14 US disclosed
US-20120213854-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS CERULEAN PHARMA INC. 2012-08-23 US disclosed
US-20100285144-A1 POLYMER-EPOTHILONE CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE CERULEAN PHARMA INC. 2010-11-11 US disclosed
CN-101045936-B Process of preparing chiral fatty alcohol with acid anhydride as acry radical donor UNIV JILIN 2010-06-23 CN disclosed
WO-2009077113-A2 HARDENING COMPOSITION DENTSPLY DETREY GMBH (DE) 2009-06-25 WO disclosed
EP-2070507-A1 Hardening composition Dentsply DeTrey GmbH (DE) 2009-06-17 EP disclosed
EP-2042892-A2 Optical film, polarizing plate, and image display apparatus FUJIFILM Corporation (JP) 2009-04-01 EP disclosed
EP-1944300-A2 Prodrugs of aspartyl protease inhibitors Vertex Pharmaceuticals Incorporated (US) 2008-07-16 EP disclosed
WO-2008073459-A1 ARYL SULFAMIDE DERIVATIVES AND METHODS OF THEIR USE WYETH (US) 2008-06-19 WO disclosed
EP-0933372-B1 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors VERTEX PHARMA (US) 2007-12-26 EP disclosed
EP-1287006-B1 ANTITUMORAL COMPOUNDS PHARMA MAR SA (ES) 2007-10-24 EP disclosed
CN-101045936-A Process of preparing chiral fatty alcohol with acid anhydride as acry radical donor UNIV JILIN (CN) 2007-10-03 CN disclosed